Brucella abortus RB51: enhancing vaccine efficacy and developing multivalent vaccines

Agranovich, 1999, Down-regulation of Th2 responses by B. abortus, a strong Th1 stimulus, correlates with alterations in the B7.2-CD28 pathway, Infect. Immun., 67, 4418, 10.1128/IAI.67.9.4418-4426.1999 Araya, 1990, Comparative protection of mice against virulent and attenuated strains of B. abortus by passive transfer of immune T-cells or serum, Infect. Immun., 58, 254, 10.1128/IAI.58.1.254-256.1990 Brandt, 2000, ESAT-6 subunit vaccination against M. tuberculosis, Infect. Immun., 68, 791, 10.1128/IAI.68.2.791-795.2000 Cheville, 1992, Bacterial survival, lymph node changes, and immunologic responses of cattle vaccinated with standard and mutant strains of B. abortus, Am. J. Vet. Res., 53, 1881 Cheville, 1993, Immune responses and protection against infection and abortion in cattle experimentally vaccinated with mutant strains of B. abortus, Am. J. Vet. Res., 54, 1591 Elzer, 1995, In vivo and in vitro stability of the broad-host-range cloning vector pBBR1MCS in six Brucella species, Plasmid, 33, 51, 10.1006/plas.1995.1006 Golding, 1995, B. abortus conjugated with a gp120 or V3 loop peptide derived from human immunodeficiency virus (HIV) type 1 induces neutralizing anti-HIV antibodies, and the V3–B. abortus conjugate is effective even after CD4+ T-cell depletion, J. Virol., 69, 3299, 10.1128/JVI.69.6.3299-3307.1995 Harboe, 1996, Evidence for occurrence of the ESAT-6 protein in M. tuberculosis and virulent M. bovis and for its absence in M. bovis BCG, Infect. Immun., 64, 16, 10.1128/IAI.64.1.16-22.1996 He, 2001, Mice vaccinated with B. abortus RB51 develop specific cytotoxic lymphocytes, Infect. Immun., 69, 5502, 10.1128/IAI.69.9.5502-5508.2001 Hombach, 1995, Strictly transporter of antigen presentation (TAP)-dependent presentation of an immunodominant cytotoxic T-lymphocyte epitope in the signal sequence of a virus protein, Exp. Med., 182, 1615, 10.1084/jem.182.5.1615 Jensen, 1996, Determination of stability of B. abortus RB51 by use of genomic fingerprint, oxidative metabolism, and colonial morphology and differentiation of strain RB51 from B. abortus isolates from bison and elk, J. Clin. Microbiol., 34, 628, 10.1128/JCM.34.3.628-633.1996 Kovach, 1995, Four new derivatives of the broad-host-range cloning vector pBBR1MCS, carrying different antibiotic-resistance cassettes, Gene, 166, 175, 10.1016/0378-1119(95)00584-1 Kovach, 1994, pBBR1MCS: a broad-host-range cloning vector, Biotechniques, 16, 800 Lapham, 1996, B. abortus conjugated with a peptide derived from the V3 loop of human immunodeficiency virus (HIV) type 1 induces HIV-specific cytotoxic T-cell responses in normal and in CD4+ cell-depleted BALB/c mice, J. Virol., 70, 3084, 10.1128/JVI.70.5.3084-3092.1996 Littell, R.C., Milliken, G.A., Stroup, W.W., Wolfinger, R.D., 1996. SAS® system for mixed models. SAS Institute Inc., Cary, NC. Lord, 1998, Field study of vaccination of cattle with B. abortus strains RB51 and 19 under high and low disease prevalence, Am. J. Vet. Res., 59, 1016 Lozes, 1997, Immunogenicity and efficacy of a tuberculosis DNA vaccine encoding the components of the secreted antigen 85 complex, Vaccine, 15, 830, 10.1016/S0264-410X(96)00274-5 Martoglio, 1998, Signal sequences: more than just greasy peptides, Trends Cell Biol., 8, 410, 10.1016/S0962-8924(98)01360-9 McQuiston, 1995, Transformation of Brucella species with suicide and broad host-range plasmids, Methods Mol. Biol., 47, 143 Palmer, 1997, Safety and immunogenicity of B. abortus strain RB51 vaccine in pregnant cattle, Am. J. Vet. Res., 58, 472 Schurig, 1991, Biological properties of RB51: a stable rough strain of B. abortus, Vet. Microbiol., 28, 171, 10.1016/0378-1135(91)90091-S Scott, 1997, Inhibition of primary and recall allergen-specific T-helper cell type 2-mediated responses by a T-helper cell type 1 stimulus, J. Immunol., 159, 107, 10.4049/jimmunol.159.1.107 Sorensen, 1995, Purification and characterization of a low-molecular-mass T-cell antigen secreted by M. tuberculosis, Infect. Immun., 63, 1710, 10.1128/IAI.63.5.1710-1717.1995 Tabatabai, 1994, Modulation of immune responses in Balb/c mice vaccinated with B. abortus Cu–Zn superoxide dismutase synthetic peptide vaccine, Vaccine, 12, 919, 10.1016/0264-410X(94)90035-3 Velaz-Faircloth, 1999, Protection against Mycobacterium avium by DNA vaccines expressing mycobacterial antigens as fusion proteins with green fluorescent protein, Infect. Immun., 67, 4243, 10.1128/IAI.67.8.4243-4250.1999 Vemulapalli, 2000, Characterization of specific immune responses of mice inoculated with recombinant vaccinia virus expressing an 18-kDa outer membrane protein of B. abortus, Clin. Diagn. Lab. Immunol., 7, 114, 10.1128/CDLI.7.1.114-118.2000 Vemulapalli, 2000, B. abortus RB51 as a vector for heterologous protein expression and induction of specific Th1 type immune responses, Infect. Immun., 68, 3290, 10.1128/IAI.68.6.3290-3296.2000 Vemulapalli, 2000, Overexpression of protective antigen as a novel approach to enhance vaccine efficacy of B. abortus strain RB51, Infect. Immun., 68, 3286, 10.1128/IAI.68.6.3286-3289.2000 Vemulapalli, 1998, Cloning and sequencing of yajC and secD homologs of B. abortus and demonstration of immune responses to YajC in mice vaccinated with B. abortus RB51, Infect. Immun., 66, 5684, 10.1128/IAI.66.12.5684-5691.1998 Wiker, 1992, The antigen 85 complex: a major secretion product of Mycobacterium tuberculosis, Microbiol. Rev., 56, 648, 10.1128/MMBR.56.4.648-661.1992 Zaitseva, 1995, Human peripheral blood CD4+ and CD8+ T-cells express Th1-like cytokine mRNA and proteins following in vitro stimulation with heat-inactivated B. abortus, Infect. Immun., 63, 2720, 10.1128/IAI.63.7.2720-2728.1995